January 5, 2022
NCPA and APC to brief prescribers on BUD issues Jan. 20
Maybe you’re already aware of a proposal from the U.S. Pharmacopeia that would restrict beyond-use dates for many compounded medications you dispense. But there’s a good chance the prescribers you work with are NOT aware of the proposed changes — and what they don’t know can hurt them and their ability to care for their patients.
That’s why NCPA and APC are co-hosting a 30-minute virtual briefing on January 20 especially for providers you work with — the physicians, physician assistants, and nurse practitioners who prescribe compounded medications for their patients.
But here’s the thing: We don’t know the prescribers you work with. We don’t have their email addresses. So we’re counting on YOU to make them aware of the briefing and urge that they participate.
USP has set a January 31 deadline for comments on its proposals. The aim of this briefing is to inform prescribers so they can join us in expressing concern to USP by the comment deadline.
Thanks in advance for helping us engage your prescribers on this important patient access issue. But hurry, please: January 20 is not far away!
